HAMP and infection: Thus, because provision of iron to infants with infections may be dangerous in certain settings, more research is clearly needed on the potential utility of hepcidin as a point-of-care marker to increase the safety of iron supplementation in infants and children in the developing world, as has been proposed [12], [13].